-
Mail Us services@iebrain.com
-
US | INDIA +1-202-697-9162 | +91-124-429-4218
Blockchain is touted to be a solution to complex problems in various industrial domains. The use of blockchain, especially in the automotive industry, is seen as the next disruptive technology. With the advent of cryptocurrencies, consortium formation, and implementations, blockchain is not far from being used along with current technologies and ultimately replacing them. Blockchain has great potential but also comes with specific challenges that the companies are trying to overcome. The use of blockchain in automotive is also indicated by the IP being filed by the companies. A lot of start-ups are also working in the implementation of blockchain in automotive. Through this whitepaper, we tried to focus on opportunities and implementation of blockchain along with potential issues for implementation. We also focused on IP related to automotive blockchain and patenting activity happening in the US.
Quantum computing is the most hyped and latest buzz around the corner. Quantum computing is evolving from rational thought to technological reality, and this is also occurring in the IP realm. Inventions in this industry might easily be a source of concern for patent specialists. Through this whitepaper, we tried to focus on issues faced while patenting quantum computing invention, should one file a patent or not, consequences being faced by it to become a reality, and are there any better possible solutions available other than patents.
The world is fighting an outbreak of respiratory disease, COVID-19, caused by the SARS-CoV-2 virus. Pharmaceutical companies worldwide have worked very hard and come up with vaccinations to treat and prevent the disease. Although vaccines developed are highly efficient in preventing the disease’s adverse events but still not for the treatment. On the other hand, cell and gene therapies are promising life-changing treatments for several death-causing diseases. Our team tried to focus on some key challenges that a company could face during the development of gene therapy for COVID-19 treatment and possible ways to overcome those in this whitepaper.
As the world is struggling to contain the novel coronavirus (COVID-19) outbreak, healthcare infrastructure, and testing capacity have emerged as major issues. Based on our continuing research and service for our customers across the globe, we have various solutions for our clients to deal with such a situation of crisis and balance their business. There are various Institutions that have already developed their COVID-19 diagnostic kit, and some are still working on it. This report also covers the diagnosis of Covid-19 testing overview, methods and techniques. Comparison of results from different test types and Challenges faced during the development of the COVID-19 diagnostic kit.
COVID-19 pandemic has caused a tremendous shift in medical focus from almost every disorder to COVID-19 treatment. It has been observed that each step in the cancer management pathway has been disrupted by the COVID-19 virus that is the diagnosis, screening, treatment, research and development. This pandemic will most certainly continue to have an impact on cancer patients and their treatment for the foreseeable future.
Through this whitepaper, we have enlightened about the effect of COVID-19 on oncology diagnosis, screening, patient outcomes, treatment modalities, clinical trials, availability of drugs, clinical advancements and what pharmaceutical companies are doing to fight with this situation.
This whitepaper describes the fundamentals of design patent and different aspects of design search. Different paid and free databases that support design search and the type of input required by these databases are also described. This paper further includes an example of national and international classifications and the importance of Locarno classification in design search with a case study mentioning exemplary search results that are gathered using and without using Locarno classifications.
The human microbiome has fascinated scientists for decades. With the advances in sequencing techniques, it has finally become possible for researchers to start putting the pieces of the puzzle together. An entire industry dedicated to Microbiome Therapeutics is slowly taking shape, the sole purpose of which is to identify treatments for ailments such as cancer and autism based on the minor alteration of the body microbiome. Although the human microbiome consists of bacterial, fungal and viral species, currently the industry is focused on the bacterial part of the microbiome.
Renaissance took a lot of pain to take over the dark age of knowledge. A man was unaware of the living beings and varieties of species surrounding him Nobody in that era would have thought that a day would come when evolution will not seem magical instead man himself would become capable of instigating evolution. It is said that true powers lie in bringing out a change that we want to see and it is true philosophically as well as genetically.
Every new development in the field of technology creates disruption making the past technological standards obsolete and those who still use it, is just for the nostalgia (Bodkin,2005) factor or lack of platform alternatives (Warren,2015). Blockchain is an online record-keeping innovation that will change how we conduct business It is a mutual, trusted, public record of exchanges,
that everybody can investigate however no single client controls it. It is also crypto-graphed, secure, and tamper-resistant that cannot be re-circulated.
One of the most promising areas of health innovations is the application of artificial intelligence (AI), primarily in medical imaging. With an irreversible increase in the amount of data and the possibility to use AI to identify findings either detectable or not by the human eye, radiology is now moving from a subjective perceptual skill to a more objective science. These technologies have the capability to Sense, Comprehend, Act and Learn. AI is essentially a smart solution for compiling and analyzing data, taking account of more variables than humans can, categorizing the new data, predicting trends and ultimately identifying solutions.